The surgical treatment of pulmonary histoplasmosis with an evaluation of MRD-112 as a possible adjunct.
D000935:Antifungal Agents / Q000627:therapeutic use*; D003517:Cyclopentanes / Q000627:therapeutic use*; D005659:Fungicides, Industrial; D006660:Histoplasmosis / Q000628:therapy*; D006801:Humans; D008172:Lung Diseases, Fungal
D000935:Antifungal Agents; D003517:Cyclopentanes; D005659:Fungicides, Industrial
CYCLOPENTANES/therapeutic use; FUNGICIDES/therapeutic use; HISTOPLASMOSIS/therapy